X-linked TLR7 deficiency has been identified as a novel immunodeficiency with an increased susceptibility to severe or critical COVID-19 infection and TLR7 has been established as a critical mediator of IFN-I immunity against the virus (Solanich et al., 2021). The gene discussed is TLR7; the disease is immune system disorder.